Lyme disease vaccine candidate VLA15: More positive Phase 2 results, including booster response reported
by Press Release from Outbreak News Today on (#5Q3NT)
By NewsDesk @infectiousdiseasenews Vaccine company, Valneva and Pfizer today announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15. The Phase 2 study, VLA15-202, is evaluating the immunogenicity and safety of VLA15 in a Month 0-2-6 vaccination schedule. The study enrolled 246 healthy adults 18 to 65 years of age in [...]
The post Lyme disease vaccine candidate VLA15: More positive Phase 2 results, including booster response reported appeared first on Outbreak News Today.